EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fangchinoline derivative LYY-34 suppresses TNBC by inhibiting BLM DNA helicase from unfolding of c-MYC promoter G-quadruplex DNA

Xiaohua Liu, Wenfang Zhang, Wangming Zhang, Junjie Lan, Shan-Shan Song, Long Yang, Weidong Pan, Yixin Liu, Chao-Da Xiao, Jielin Liu

Biochemical Pharmacology · 2026-08 · 250 · 117945

DOI: 10.1016/j.bcp.2026.117945 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Pharmacology, 2026-08. Verfasst von Xiaohua Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Basic Medical College, Guizhou Medical University, Guiyang 561113, PR China. Hauptthemen laut MEDLINE: G-Quadruplexes, RecQ Helicases, Promoter Regions, Genetic, Triple Negative Breast Neoplasms. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guizhou Medical University, National Natural Science Foundation of China, Guizhou Province Science and Technology Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Excessive unfolding of G-quadruplex (G4) DNA in the c-MYC oncogene promoter leads to its overexpression and promotes cancer progression. Triple-negative breast cancer (TNBC) frequently exhibits c-MYC amplification. Bloom syndrome (BLM) DNA helicase can efficiently unwind c-MYC promoter G4 DNA. This study investigated the antitumor mechanism of the fangchinoline derivative LYY-34 on TNBC by targeting BLM DNA helicase-mediated unfolding of c-MYC promoter G4 DNA. We first demonstrated that LYY-34 inhibits the binding and unfolding activities of BLM DNA helicase on c-MYC promoter G4 DNA. Furthermore, we found that this inhibition primarily results from LYY-34 competitively binding to the 3'-DNA overhang of the c-MYC promoter G4 and directly interacting with BLM DNA helicase, thereby suppressing BLM DNA helicase activity, rather than stabilizing the G4 structure. Bioinformatics analysis combined with in vitro experiments showed that BLM DNA helicase modulates c-MYC expression. In addition, both in vitro and in vivo antiproliferation experiments demonstrated that LYY-34 significantly suppresses TNBC. Further studies revealed that this inhibitory effect is associated with its suppression of BLM DNA helicase and c-MYC expression. In summary, LYY-34 may serve as a potential therapeutic agent for TNBC by inhibiting the BLM DNA helicase /c-MYC axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

G-QuadruplexesRecQ HelicasesPromoter Regions, GeneticTriple Negative Breast NeoplasmsBenzylisoquinolinesProto-Oncogene Proteins c-mycAntineoplastic AgentsHumansAnimalsCell Line, TumorFemaleMice, NudeMice

Stichwörter der Autor:innen

BLM DNA helicaseFangchinoline derivativeG-quadruplexProliferationTriple-negative breast cancerc-MYC

Substanzen

RecQ HelicasesfangchinolineBenzylisoquinolinesProto-Oncogene Proteins c-mycBloom syndrome proteinAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Immunology, Basic Medical College, Guizhou Medical University, Guiyang 561113, PR China.
  • Department of Immunology, Basic Medical College, Guizhou Medical University, Guiyang 561113, PR China; Beijing Jishuitan Hospital Guizhou Hospital, Guiyang 550000, PR China.
  • Department of Pharmacy, Guizhou Provincial People's Hospital, 550002 Guiyang, PR China.
  • The High Efficacy Application of Natural Medicinal Resources Engineering Center of Guizhou Province and The High Educational Key Laboratory of Guizhou Province for Natural Medicinal Pharmacology and Druggability, School…
  • State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Guizhou Medical University, Guiyang 561113, PR China; Natural Products Research Center of Guizhou Province, Gui…
  • Department of Pharmacology, Basic Medical College, Guizhou Medical University, Guiyang 561113, PR China. Electronic address: liuyixin@gmc.edu.cn.

Förderung

  • Guizhou Medical University
  • National Natural Science Foundation of China
  • Guizhou Province Science and Technology Foundation

Zitieren

APA

Liu, X., Zhang, W., Zhang, W., Lan, J., Song, S. S., Yang, L., Pan, W., Liu, Y., Xiao, C. D., & Liu, J. (2026). Fangchinoline derivative LYY-34 suppresses TNBC by inhibiting BLM DNA helicase from unfolding of c-MYC promoter G-quadruplex DNA. Biochemical Pharmacology, 250, 117945. https://doi.org/10.1016/j.bcp.2026.117945

Vancouver

Liu X, Zhang W, Zhang W, Lan J, Song SS, Yang L, et al. Fangchinoline derivative LYY-34 suppresses TNBC by inhibiting BLM DNA helicase from unfolding of c-MYC promoter G-quadruplex DNA. Biochemical Pharmacology. 2026;250:117945. doi:10.1016/j.bcp.2026.117945

BibTeX
@article{Liu2026,
  author = {Liu, Xiaohua and Zhang, Wenfang and Zhang, Wangming and Lan, Junjie and Song, Shan-Shan and Yang, Long and Pan, Weidong and Liu, Yixin and Xiao, Chao-Da and Liu, Jielin},
  title = {Fangchinoline derivative LYY-34 suppresses TNBC by inhibiting BLM DNA helicase from unfolding of c-MYC promoter G-quadruplex DNA},
  journal = {Biochemical Pharmacology},
  year = {2026},
  volume = {250},
  pages = {117945},
  doi = {10.1016/j.bcp.2026.117945}
}
Kostenlos starten →